Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin L Moore

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Journal of Virology|November 6, 2015
Priming of the Respiratory Tract with Immunobiotic Lactobacillus plantarum Limits Infection of Alveolar Macrophages with Recombinant Pneumonia Virus of Mice (rK2-PVM)Kimberly D Dyer, Rebecca A Drummond, Tyler A Rice, et al.
Journal of Virology|July 4, 2014
Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c miceSeyhan Boyoglu-Barnum, Tatiana Chirkova, Sean O Todd, et al.
Immune Network|July 9, 2019
Respiratory Syncytial Virus Fusion Protein-encoding DNA Vaccine Is Less Effective in Conferring Protection against Inflammatory Disease than a Virus-like Particle PlatformYoung-Man Kwon, Hye Suk Hwang, Young-Tae Lee, et al.
Journal of Virology|July 26, 2013
A respiratory syncytial virus (RSV) anti-G protein F(ab')2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c miceSeyhan Boyoglu-Barnum, Kelsey A Gaston, Sean O Todd, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 4, 2017
STAT1 Represses Cytokine-Producing Group 2 and Group 3 Innate Lymphoid Cells during Viral InfectionMatthew T Stier, Kasia Goleniewska, Jacqueline Y Cephus, et al.
Journal of Virology|June 13, 2014
STAT4 deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus (RSV) challenge but enhances the lung RSV-specific CD8+ T cell immune response to secondary challengeDaniel E Dulek, Dawn C Newcomb, Shinji Toki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 13, 2005
Allergen-induced airway hyperresponsiveness mediated by cyclooxygenase inhibition is not dependent on 5-lipoxygenase or IL-5, but is IL-13 dependentR Stokes Peebles, Koichi Hashimoto, James R Sheller, et al.
Human Vaccines & Immunotherapeutics|January 28, 2017
Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton ratsHye Suk Hwang, Ki-Hye Kim, Youri Lee, et al.
Journal of Virology|June 10, 2016
A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton RatsChristina A Rostad, Christopher C Stobart, Brian E Gilbert, et al.
Microbes and Infection|November 18, 2006
IL-13 is associated with reduced illness and replication in primary respiratory syncytial virus infection in the mouseWeisong Zhou, Koichi Hashimoto, Martin L Moore, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Journal of Virology|November 6, 2015
Priming of the Respiratory Tract with Immunobiotic Lactobacillus plantarum Limits Infection of Alveolar Macrophages with Recombinant Pneumonia Virus of Mice (rK2-PVM)Kimberly D Dyer, Rebecca A Drummond, Tyler A Rice, et al.
Journal of Virology|July 4, 2014
Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c miceSeyhan Boyoglu-Barnum, Tatiana Chirkova, Sean O Todd, et al.
Immune Network|July 9, 2019
Respiratory Syncytial Virus Fusion Protein-encoding DNA Vaccine Is Less Effective in Conferring Protection against Inflammatory Disease than a Virus-like Particle PlatformYoung-Man Kwon, Hye Suk Hwang, Young-Tae Lee, et al.
Journal of Virology|July 26, 2013
A respiratory syncytial virus (RSV) anti-G protein F(ab')2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c miceSeyhan Boyoglu-Barnum, Kelsey A Gaston, Sean O Todd, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 4, 2017
STAT1 Represses Cytokine-Producing Group 2 and Group 3 Innate Lymphoid Cells during Viral InfectionMatthew T Stier, Kasia Goleniewska, Jacqueline Y Cephus, et al.
Journal of Virology|June 13, 2014
STAT4 deficiency fails to induce lung Th2 or Th17 immunity following primary or secondary respiratory syncytial virus (RSV) challenge but enhances the lung RSV-specific CD8+ T cell immune response to secondary challengeDaniel E Dulek, Dawn C Newcomb, Shinji Toki, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 13, 2005
Allergen-induced airway hyperresponsiveness mediated by cyclooxygenase inhibition is not dependent on 5-lipoxygenase or IL-5, but is IL-13 dependentR Stokes Peebles, Koichi Hashimoto, James R Sheller, et al.
Human Vaccines & Immunotherapeutics|January 28, 2017
Virus-like particle vaccines containing F or F and G proteins confer protection against respiratory syncytial virus without pulmonary inflammation in cotton ratsHye Suk Hwang, Ki-Hye Kim, Youri Lee, et al.
Journal of Virology|June 10, 2016
A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton RatsChristina A Rostad, Christopher C Stobart, Brian E Gilbert, et al.
Microbes and Infection|November 18, 2006
IL-13 is associated with reduced illness and replication in primary respiratory syncytial virus infection in the mouseWeisong Zhou, Koichi Hashimoto, Martin L Moore, et al.
Pageof 9